About Cellular Longevity
Cellular Longevity is a private company based in San Francisco, California. It has reported $137,295,169 raised in six offerings on Form D since January 2020. Its chief executive is Celine-Lea Halioua-Haubold.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 11, 2024 | Oct 28, 2024 | $22,174,971of $32.4M target | 12 | $1.8M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 5, 2024 | Mar 29, 2024 | $76,280,239fully sold | 38 | $2.0M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 31, 2021 | Oct 1, 2021 | $27,697,449of $28.8M target | 42 | $659K | Equity, Series A Preferred StockRule 506(b) | Form D ↗ |
| Sep 3, 2020 | Jun 25, 2021 | $5,449,999fully sold | 28 | $194K | EquityRule 506(b) | Form D ↗ |
| Dec 17, 2020 | Jun 25, 2021 | $831,521of $4.0M target | 10 | $83,152 | OptionsRule 506(b) | Form D ↗ |
| Jan 3, 2020 | Jan 16, 2020 | $4,860,990of $4.8M target | 19 | $255K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $137,295,169 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cellular Longevity's Form D filed Oct 28, 2024.
LD
Laura Deming
Director
LR
Linda Rhodes
Director
CH
Celine-Lea Halioua-Haubold
Chief Executive Officer and director
KZ
BS
Blake Scholl
Director